"Designing Growth Strategies is in our DNA"

Central Nervous System Biomarkers Market Size, Share & Industry Analysis, By Biomarker Type (Molecular Biomarkers, Imaging Biomarkers, Electrophysiological & Physiological Biomarkers, and Others), By Application (Disease Diagnosis, Drug Discovery & Development, Disease Risk Assessment, and Others), By Disease Indication (Alzheimer Disease, Parkinson’s Disease, Multiple Sclerosis, Traumatic Brain Injury, and Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Others), and Regional Forecast, 2026-2034

Last Updated: October 18, 2026 | Format: PDF | Report ID: FBI119462

 

Buy Now

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities 
    4. Market Challenges
    5. Market Trends
  4. Key Insights
    1. Prevalence of Key Disorders, Key Countries/Regions, 2025
    2. Technological Advancements in Central Nervous System Biomarkers 
    3. New Product Launches, Key Players 
    4. Key Industry Developments - Mergers, Acquisitions & Partnerships
  5. Global Central Nervous System Biomarkers Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Molecular Biomarkers
      2. Imaging Biomarkers
      3. Electrophysiological & Physiological Biomarkers
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Disease Risk Assessment
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Alzheimer's Disease
      2. Parkinson's Disease
      3. Multiple Sclerosis
      4. Traumatic Brain Injury
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Central Nervous System Biomarkers Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Molecular Biomarkers
      2. Imaging Biomarkers
      3. Electrophysiological & Physiological Biomarkers
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Disease Risk Assessment
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Alzheimer's Disease
      2. Parkinson's Disease
      3. Multiple Sclerosis
      4. Traumatic Brain Injury
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Application
      2. Canada
        1. By Application
  7. Europe Central Nervous System Biomarkers Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Molecular Biomarkers
      2. Imaging Biomarkers
      3. Electrophysiological & Physiological Biomarkers
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Disease Risk Assessment
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Alzheimer's Disease
      2. Parkinson's Disease
      3. Multiple Sclerosis
      4. Traumatic Brain Injury
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
        1. By Application
      2. Germany
        1. By Application
      3. France
        1. By Application
      4. Spain
        1. By Application
      5. Italy
        1. By Application
      6. Scandinavia
        1. By Application
      7. Rest of Europe
        1. By Application
  8. Asia Pacific Central Nervous System Biomarkers Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Molecular Biomarkers
      2. Imaging Biomarkers
      3. Electrophysiological & Physiological Biomarkers
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Disease Risk Assessment
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Alzheimer's Disease
      2. Parkinson's Disease
      3. Multiple Sclerosis
      4. Traumatic Brain Injury
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
        1. By Application
      2. Australia 
        1. By Application
      3. China
        1. By Application
      4. India
        1. By Application
      5. Southeast Asia
        1. By Application
      6. Rest of Asia Pacific
        1. By Application
  9. Latin America Central Nervous System Biomarkers Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Molecular Biomarkers
      2. Imaging Biomarkers
      3. Electrophysiological & Physiological Biomarkers
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Disease Risk Assessment
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Alzheimer's Disease
      2. Parkinson's Disease
      3. Multiple Sclerosis
      4. Traumatic Brain Injury
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil 
        1. By Application
      2. Mexico 
        1. By Application
      3. Rest of Latin America
        1. By Application
  10. Middle East & Africa Central Nervous System Biomarkers Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Molecular Biomarkers
      2. Imaging Biomarkers
      3. Electrophysiological & Physiological Biomarkers
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Disease Risk Assessment
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Alzheimer's Disease
      2. Parkinson's Disease
      3. Multiple Sclerosis
      4. Traumatic Brain Injury
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
        1. By Application
      2. South Africa
        1. By Application
      3. Rest of Middle East & Africa
        1. By Application
  11. Competitive Analysis 
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability) 
      1. F. Hoffmann-La Roche Ltd. 
      2. Thermo Fisher Scientific Inc. 
      3. QIAGEN 
      4. Fujirebio 
      5. GE Healthcare 
      6. Labcorp 
      7. Quest Diagnostics 
      8. Beckman Coulter, Inc. 
      9. Siemens Healthineers AG 
      10. Bio-Techne
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities 
    4. Market Challenges
    5. Market Trends
  4. Key Insights
    1. Prevalence of Key Disorders, Key Countries/Regions, 2025
    2. Technological Advancements in Central Nervous System Biomarkers 
    3. New Product Launches, Key Players 
    4. Key Industry Developments - Mergers, Acquisitions & Partnerships
  5. Global Central Nervous System Biomarkers Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Molecular Biomarkers
      2. Imaging Biomarkers
      3. Electrophysiological & Physiological Biomarkers
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Disease Risk Assessment
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Alzheimer's Disease
      2. Parkinson's Disease
      3. Multiple Sclerosis
      4. Traumatic Brain Injury
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Central Nervous System Biomarkers Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Molecular Biomarkers
      2. Imaging Biomarkers
      3. Electrophysiological & Physiological Biomarkers
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Disease Risk Assessment
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Alzheimer's Disease
      2. Parkinson's Disease
      3. Multiple Sclerosis
      4. Traumatic Brain Injury
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Application
      2. Canada
        1. By Application
  7. Europe Central Nervous System Biomarkers Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Molecular Biomarkers
      2. Imaging Biomarkers
      3. Electrophysiological & Physiological Biomarkers
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Disease Risk Assessment
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Alzheimer's Disease
      2. Parkinson's Disease
      3. Multiple Sclerosis
      4. Traumatic Brain Injury
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
        1. By Application
      2. Germany
        1. By Application
      3. France
        1. By Application
      4. Spain
        1. By Application
      5. Italy
        1. By Application
      6. Scandinavia
        1. By Application
      7. Rest of Europe
        1. By Application
  8. Asia Pacific Central Nervous System Biomarkers Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Molecular Biomarkers
      2. Imaging Biomarkers
      3. Electrophysiological & Physiological Biomarkers
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Disease Risk Assessment
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Alzheimer's Disease
      2. Parkinson's Disease
      3. Multiple Sclerosis
      4. Traumatic Brain Injury
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
        1. By Application
      2. Australia 
        1. By Application
      3. China
        1. By Application
      4. India
        1. By Application
      5. Southeast Asia
        1. By Application
      6. Rest of Asia Pacific
        1. By Application
  9. Latin America Central Nervous System Biomarkers Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Molecular Biomarkers
      2. Imaging Biomarkers
      3. Electrophysiological & Physiological Biomarkers
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Disease Risk Assessment
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Alzheimer's Disease
      2. Parkinson's Disease
      3. Multiple Sclerosis
      4. Traumatic Brain Injury
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil 
        1. By Application
      2. Mexico 
        1. By Application
      3. Rest of Latin America
        1. By Application
  10. Middle East & Africa Central Nervous System Biomarkers Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Biomarker Type
      1. Molecular Biomarkers
      2. Imaging Biomarkers
      3. Electrophysiological & Physiological Biomarkers
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Disease Risk Assessment
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Alzheimer's Disease
      2. Parkinson's Disease
      3. Multiple Sclerosis
      4. Traumatic Brain Injury
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
        1. By Application
      2. South Africa
        1. By Application
      3. Rest of Middle East & Africa
        1. By Application
  11. Competitive Analysis 
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability) 
      1. F. Hoffmann-La Roche Ltd. 
      2. Thermo Fisher Scientific Inc. 
      3. QIAGEN 
      4. Fujirebio 
      5. GE Healthcare 
      6. Labcorp 
      7. Quest Diagnostics 
      8. Beckman Coulter, Inc. 
      9. Siemens Healthineers AG 
      10. Bio-Techne
Read Less

Figure 1:  Global Central Nervous System Biomarkers Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2:  Global Central Nervous System Biomarkers Market Value Share (%), by Biomarker Type, 2025 & 2034

Figure 3:  Global Central Nervous System Biomarkers Market Value Share (%), By Application, 2025 & 2034

Figure 4:  Global Central Nervous System Biomarkers Market Value Share (%), by Disease Indication, 2025 & 2034

Figure 5:  Global Central Nervous System Biomarkers Market Value Share (%), by End User, 2025 & 2034

Figure 6:  Global Central Nervous System Biomarkers Market Value Share (%), by Region, 2025 & 2034

Figure 7:  North America Central Nervous System Biomarkers Market Value (USD billion), by Biomarker Type, 2025 & 2034

Figure 8:  North America Central Nervous System Biomarkers Market Value Share (%), by Biomarker Type, 2025

Figure 9:  North America Central Nervous System Biomarkers Market Value (USD billion), By Application, 2025 & 2034

Figure 10:  North America Central Nervous System Biomarkers Market Value Share (%), By Application, 2025

Figure 11:  North America Central Nervous System Biomarkers Market Value (USD billion), by Disease Indication, 2025 & 2034

Figure 12:  North America Central Nervous System Biomarkers Market Value Share (%), by Disease Indication, 2025

Figure 13:  North America Central Nervous System Biomarkers Market Value (USD billion), by End User, 2025 & 2034

Figure 14:  North America Central Nervous System Biomarkers Market Value Share (%), by End User, 2025

Figure 15:  North America Central Nervous System Biomarkers Market Value (USD billion), By Country, 2025 & 2034

Figure 16:  North America Central Nervous System Biomarkers Market Value Share (%), By Country, 2025

Figure 17:  Europe Central Nervous System Biomarkers Market Value (USD billion), by Biomarker Type, 2025 & 2034

Figure 18:  Europe Central Nervous System Biomarkers Market Value Share (%), by Biomarker Type, 2025

Figure 19:  Europe Central Nervous System Biomarkers Market Value (USD billion), By Application, 2025 & 2034

Figure 20:  Europe Central Nervous System Biomarkers Market Value Share (%), By Application, 2025

Figure 21:  Europe Central Nervous System Biomarkers Market Value (USD billion), by Disease Indication, 2025 & 2034

Figure 22:  Europe Central Nervous System Biomarkers Market Value Share (%), by Disease Indication, 2025

Figure 23:  Europe Central Nervous System Biomarkers Market Value (USD billion), by End User, 2025 & 2034

Figure 24:  Europe Central Nervous System Biomarkers Market Value Share (%), by End User, 2025

Figure 25:  Europe Central Nervous System Biomarkers Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 26:  Europe Central Nervous System Biomarkers Market Value Share (%), By Country/ Sub-region, 2025

Figure 27:  Asia Pacific Central Nervous System Biomarkers Market Value (USD billion), by Biomarker Type, 2025 & 2034

Figure 28:  Asia Pacific Central Nervous System Biomarkers Market Value Share (%), by Biomarker Type, 2025

Figure 29:  Asia Pacific Central Nervous System Biomarkers Market Value (USD billion), By Application, 2025 & 2034

Figure 30:  Asia Pacific Central Nervous System Biomarkers Market Value Share (%), By Application, 2025

Figure 31:  Asia Pacific Central Nervous System Biomarkers Market Value (USD billion), by Disease Indication, 2025 & 2034

Figure 32:  Asia Pacific Central Nervous System Biomarkers Market Value Share (%), by Disease Indication, 2025

Figure 33:  Asia Pacific Central Nervous System Biomarkers Market Value (USD billion), by End User, 2025 & 2034

Figure 34:  Asia Pacific Central Nervous System Biomarkers Market Value Share (%), by End User, 2025

Figure 35:  Asia Pacific Central Nervous System Biomarkers Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 36:  Asia Pacific Central Nervous System Biomarkers Market Value Share (%), By Country/ Sub-region, 2025

Figure 37:  Latin America Central Nervous System Biomarkers Market Value (USD billion), by Biomarker Type, 2025 & 2034

Figure 38:  Latin America Central Nervous System Biomarkers Market Value Share (%), by Biomarker Type, 2025

Figure 39:  Latin America Central Nervous System Biomarkers Market Value (USD billion), By Application, 2025 & 2034

Figure 40:  Latin America Central Nervous System Biomarkers Market Value Share (%), By Application, 2025

Figure 41:  Latin America Central Nervous System Biomarkers Market Value (USD billion), by Disease Indication, 2025 & 2034

Figure 42:  Latin America Central Nervous System Biomarkers Market Value Share (%), by Disease Indication, 2025

Figure 43:  Latin America Central Nervous System Biomarkers Market Value (USD billion), by End User, 2025 & 2034

Figure 44:  Latin America Central Nervous System Biomarkers Market Value Share (%), by End User, 2025

Figure 45:  Latin America Central Nervous System Biomarkers Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 46:  Latin America Central Nervous System Biomarkers Market Value Share (%), By Country/ Sub-region, 2025

Figure 47:  Middle East & Africa Central Nervous System Biomarkers Market Value (USD billion), by Biomarker Type, 2025 & 2034

Figure 48:  Middle East & Africa Central Nervous System Biomarkers Market Value Share (%), by Biomarker Type, 2025

Figure 49:  Middle East & Africa Central Nervous System Biomarkers Market Value (USD billion), By Application, 2025 & 2034

Figure 50:  Middle East & Africa Central Nervous System Biomarkers Market Value Share (%), By Application, 2025

Figure 51:  Middle East & Africa Central Nervous System Biomarkers Market Value (USD billion), by Disease Indication, 2025 & 2034

Figure 52:  Middle East & Africa Central Nervous System Biomarkers Market Value Share (%), by Disease Indication, 2025

Figure 53:  Middle East & Africa Central Nervous System Biomarkers Market Value (USD billion), by End User, 2025 & 2034

Figure 54:  Middle East & Africa Central Nervous System Biomarkers Market Value Share (%), by End User, 2025

Figure 55:  Middle East & Africa Central Nervous System Biomarkers Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 56:  Middle East & Africa Central Nervous System Biomarkers Market Value Share (%), By Country/ Sub-region, 2025

Figure 57:  Global Central Nervous System Biomarkers Market Share (%), By Company, 2025

Table 1:  Global Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by Biomarker Type, 2021–2034

Table 2:  Global Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 3:  Global Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by Disease Indication, 2021–2034

Table 4:  Global Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 5:  Global Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by Region, 2021–2034

Table 6:  North America Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by Biomarker Type, 2021–2034

Table 7:  North America Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 8:  North America Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by Disease Indication, 2021–2034

Table 9:  North America Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 10:  North America Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Country, 2021–2034

Table 11:  U.S. Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 12:  Canada Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 13:  Europe Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by Biomarker Type, 2021–2034

Table 14:  Europe Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 15:  Europe Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by Disease Indication, 2021–2034

Table 16:  Europe Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 17:  Europe Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 18:  Germany Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 19:  U.K. Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 20:  France Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 21:  Italy Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 22:  Spain Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 23:  Scandinavia Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 24:  Rest of Europe Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 25:  Asia Pacific Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by Biomarker Type, 2021–2034

Table 26:  Asia Pacific Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 27:  Asia Pacific Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by Disease Indication, 2021–2034

Table 28:  Asia Pacific Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 29:  Asia Pacific Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 30:  China Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 31:  Japan Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 32:  India Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 33:  Australia Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 34:  Southeast Asia Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 35:  Rest of Asia Pacific Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 36:  Latin America Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by Biomarker Type, 2021–2034

Table 37:  Latin America Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 38:  Latin America Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by Disease Indication, 2021–2034

Table 39:  Latin America Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 40:  Latin America Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 41:  Brazil Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 42:  Mexico Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 43:  Rest of Latin America Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 44:  Middle East & Africa Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by Biomarker Type, 2021–2034

Table 45:  Middle East & Africa Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 46:  Middle East & Africa Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by Disease Indication, 2021–2034

Table 47:  Middle East & Africa Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 48:  Middle East & Africa Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 49:  GCC Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 50:  South Africa Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 51:  Rest of Middle East & Africa Central Nervous System Biomarkers Market Revenue (USD billion) Forecast, By Application, 2021–2034

Central Nervous System Biomarkers Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 261
Download Free Sample

    man icon
    Mail icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Customize Now
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports